Whereas this proportion is lower than observed in tumors expressing wildtype Ng2/Cspg4, because these sarcomas lacked Ng2/Cspg4 expression, we know that Ng2/Cspg4 is not required for tumor initiation. This evidence concerns the gene CSPG4 and sarcoma.